J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 537, Number 3, 701-714, December 12, 2001 DOI: 10.1113/jphysiol.2001.012541
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, M. P.
Right arrow Articles by Cannon, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, M. P.
Right arrow Articles by Cannon, S. C.
Journal of Physiology (2001), 537.3, pp. 701-714
© Copyright 2001 The Physiological Society

Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na+ channel


Masanori P. Takahashi * and Stephen C. Cannon *†


* Department of Neurology, Massachusetts General Hospital and †Department of Neurobiology, Harvard Medical School, Boston, MA 02114, USA

  1. Over twenty different missense mutations in the alpha-subunit of the adult skeletal muscle Na+ channel (hSkM1) have been identified as a cause of myotonia or periodic paralysis. We examined state-dependent mexiletine block for mutations involving the putative binding site in S6 segments (V445M, S804F, V1293I, V1589M and M1592V). Whole-cell Na+ currents were measured from wild-type (WT) and mutant channels transiently expressed in HEK cells.
  2. Use-dependent block (10 ms pulses to -10 mV, at 20 Hz) in 100 µM mexiletine was reduced modestly by mutations in IVS6 (V1589M, M1592V) and enhanced by the mutation in IS6 (V445M). For mutations in IIS6 (S804F) and IIIS6 (V1293I) use-dependent block was not statistically different from that of wild-type channels.
  3. Resting-state block (10 ms pulses to -10 mV from -150 mV, at 0.1 Hz) of S6 mutants was comparable to that of WT (dissociation constant for resting channels, KR = 650 ± 40 µM, n = 9). The S6 mutant with the greatest change in KR was V445M (KR = 794 ± 45 µM, n = 5), but this difference was only marginally significant (P = 0.047).
  4. A modified technique for estimating local anaesthetic affinity of inactivated channels was developed to reduce errors due to slow inactivation and to failure of drug binding to reach equilibrium. Mexiletine affinity for inactivated channels was reduced by mutations in IVS6 (V1589M: dissociation constant for the inactivated state (KI) = 44.7 µM; M1592V: KI = 40.0 µM) and increased by the mutation in IS6 (V445M: KI = 15.0 µM), compared to wild-type channels (KI = 28.3 µM).
  5. We conclude that the disease-associated S6 mutations in domains I-IV cause at most a 2-fold change in inactivated state affinity and have even less of an effect on resting block. Model simulations show that the reduced use-dependent block of IVS6 mutants derives primarily from an increased off-rate at hyperpolarized potentials, whereas the enhanced use-dependent block of the IS6 mutant was due to a higher affinity for inactivated V445M channels.



This article has been cited by other articles:


Home page
Biophys. JHome page
J. Nilsson, M. Madeja, F. Elinder, and P. Arhem
Bupivacaine Blocks N-Type Inactivating Kv Channels in the Open State: No Allosteric Effect on Inactivation Kinetics
Biophys. J., December 1, 2008; 95(11): 5138 - 5152.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. Szendroedi, W. Sandtner, T. Zarrabi, E. Zebedin, K. Hilber, S. C. Dudley Jr., H. A. Fozzard, and H. Todt
Speeding the Recovery from Ultraslow Inactivation of Voltage-Gated Na+ Channels by Metal Ion Binding to the Selectivity Filter: A Foot-on-the-Door?
Biophys. J., December 15, 2007; 93(12): 4209 - 4224.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. F. Sheets and D. A. Hanck
Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels
J. Physiol., July 1, 2007; 582(1): 317 - 334.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
W. Ulbricht
Sodium Channel Inactivation: Molecular Determinants and Modulation
Physiol Rev, October 1, 2005; 85(4): 1271 - 1301.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S Talon, M.-A Giroux-Metges, J.-P Pennec, C Guillet, H Gascan, and M Gioux
Rapid protein kinase C-dependent reduction of rat skeletal muscle voltage-gated sodium channels by ciliary neurotrophic factor
J. Physiol., June 15, 2005; 565(3): 827 - 841.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S.-Y. Wang, J. Mitchell, E. Moczydlowski, and G. K. Wang
Block of Inactivation-deficient Na+ Channels by Local Anesthetics in Stably Transfected Mammalian Cells: Evidence for Drug Binding Along the Activation Pathway
J. Gen. Physiol., November 29, 2004; 124(6): 691 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. K. Wang, C. Russell, and S.-Y. Wang
Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels
J. Physiol., February 1, 2004; 554(3): 621 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J.-F. Desaphy, A. D. E. Luca, M. P. Didonna, A. L. George Jr, and D. C. Camerino
Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block
J. Physiol., January 15, 2004; 554(2): 321 - 334.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. De Luca, S. Talon, M. De Bellis, J.-F. Desaphy, G. Lentini, F. Corbo, A. Scilimati, C. Franchini, V. Tortorella, and D. C. Camerino
Optimal Requirements for High Affinity and Use-Dependent Block of Skeletal Muscle Sodium Channel by N-Benzyl Analogs of Tocainide-Like Compounds
Mol. Pharmacol., October 1, 2003; 64(4): 932 - 945.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-F. Desaphy, S. Pierno, A. De Luca, P. Didonna, and D. C. Camerino
Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders
Mol. Pharmacol., March 1, 2003; 63(3): 659 - 670.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 The Physiological Society.